Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06960798

Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)

Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (Nat-Geno)

Status
Recruiting
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
University of Oklahoma · Academic / Other
Sex
Male
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to analyze tumor tissue samples from patients of Native American identity with prostate cancer. By examining these samples, researchers hope to understand how different genes in your tumor can influence treatment decisions, how your cancer progresses and the outcome of your cancer.

Detailed description

This study aims to establish a comprehensive database of Native American (NA) patients diagnosed with prostate cancer (PC), focusing on an in-depth characterization of the genomic landscape. Archived tumor tissue collected at screening and peripheral blood samples obtained within the first year of enrollment will serve as the basis for comprehensive molecular analyses. Whole exome sequencing (WES) and whole transcriptome sequencing (RNA-seq) will be performed to characterize and delineate the genomic and transcriptomic landscape of the study cohort. The study will initially enroll participants at the Stephenson Cancer Center, with planned expansion to additional sites across Oklahoma and, subsequently, to other institutions across the United States. Oversight will be maintained by the Tribal Institutional Review Board and an independent Community Advisory Board to ensure cultural appropriateness, transparency, and sustained community engagement throughout the research process. The overarching objective is to generate insights that will inform the development of personalized treatment strategies in the future.

Conditions

Interventions

TypeNameDescription
OTHERBio-specimen CollectionTissue samples will be taken from existing archived collections and sent for further analysis.
OTHERBlood DrawBlood samples will be collected within the first year of enrollment.

Timeline

Start date
2026-05-02
Primary completion
2028-05-30
Completion
2029-06-30
First posted
2025-05-07
Last updated
2026-03-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06960798. Inclusion in this directory is not an endorsement.